Brian P. Mckeon - Aug 5, 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Executive VP & CFO
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Stock symbol: IDXX
Transactions as of: Aug 5, 2021
Transactions value $: -$67,753
Form type: 4
Date filed: 8/9/2021, 05:01 PM
Previous filing: Aug 4, 2021
Next filing: Nov 10, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXX	Common Stock	Options Exercise	$0	+192	+0.73%	$0.00	26.4K	Aug 5, 2021	Direct	F1
transaction	IDXX	Common Stock	Tax liability	-$67.8K	-96	-0.36%	$705.76	26.3K	Aug 5, 2021	Direct
holding	IDXX	Common Stock						18.1K	Aug 5, 2021	by Estony McKeon Family, LLC

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IDXX	Restricted Stock Unit	Options Exercise		-192	-3.28%		5.66K	Aug 5, 2021	Common Stock	192		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes a total of 23.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.
F3	Not applicable.